STORY SUMMARY
Artificial intelligence is taking center stage in heart health on Mayo Clinic’s podcast, “Tomorrow’s Cure.” Host Kathy Waer interviews Dr. Rohan Goswami, Mayo Clinic Florida’s Director of heart transplant Research, and Javier A. Chenik, CEO of General Prognostics, about groundbreaking advancements. Dr. Goswami discusses the potential for AI and innovative technologies to prevent the need for heart transplants by predicting patient recovery and exploring 3D-printed organs from a patient’s own cells, reducing rejection and cancer risks. Chenik highlights the role of AI in managing heart health early, potentially reducing the number of patients requiring transplants. While AI may guide transplant decisions, the tactile evaluation of organs remains crucial. Learn more by watching the full conversation at tomorrowcure.com.
VIDEO
FULL STORY
In an eye-opening podcast episode from the Mayo Clinic, experts delved into the transformative impact of artificial intelligence (AI) on heart health and transplantation. Dr. Rohan Goswami, Director of Heart Transplant Research and Innovation at Mayo Clinic Florida, and Javier Achenik, co-founder and CEO of General Prognostics (GPX), were key speakers on the show, Tomorrow’s Cure. They discussed the use of AI in predicting heart recovery and potentially eliminating the need for organ transplants. Dr. Goswami highlighted two crucial pathways: using AI to predict patient recovery and leveraging 3D printing technology to create organs using a patient’s own cells, thereby mitigating rejection and cancer risks after transplantation.
Dr. Goswami introduced the Transforming Transplant Project, an initiative aimed at preventing the need for organ transplants through innovative methods. The project explores how AI can intervene earlier in the disease process, utilizing technologies and therapeutics that were previously not considered. The goal is to achieve true organ recovery or prolong the functionality of the patient’s own organs, which would be a significant advancement in the field. Such developments are pivotal, especially given the limited availability of donor hearts and the arduous wait times for patients in need of transplants.
Javier Achenik underscored the importance of preemptive care in extending the life and health of heart patients. By managing care more actively and accurately from an earlier stage, it may be possible to delay or entirely avoid the need for heart transplants. Furthermore, AI algorithms can aid in making better decisions regarding transplants by predicting patient outcomes based on antibody responses and rejection risks. However, Dr. Goswami accentuated the irreplaceable value of surgical intuition and the hands-on evaluation of donor organs, noting that AI’s true promise lies in its potential to avoid the need for transplants altogether. This evolving landscape underscores a future where AI could radically shift how heart disease and transplantation are approached.